Additionally, the study focused solely on Ki-67, and incorporating other proliferative markers (such as proliferating cell nuclear antigen as PCNA and minichromosome maintenance protein-2 as MCM-2) could provide a more comprehensive assessment of tumor behavior. The gene discussed is PCNA; the disease is neoplasm.